UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional Incentives

Not Applicable

Completed

Conditions: HIV Infections
ART
Incentives

Interventions: Other: Optimized ART linkage package
Other: Conditional lottery incentive

First Posted Date: 2019-01-17

Last Posted Date: 2019-05-30

Lead Sponsor: University of Washington

Target Recruit Count: 132

Registration Number: NCT03808194

Locations: 🇿🇦
HSRC Sweetwaters, Sweetwaters, Kwa-Zulu Natal, South Africa

Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia

Not Applicable

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Behavioral: Telephone-Based Intervention
Other: Behavioral, Psychological or Informational Intervention
Other: Questionnaire Administration

First Posted Date: 2019-01-16

Last Posted Date: 2021-06-23

Lead Sponsor: University of Washington

Target Recruit Count: 12

Registration Number: NCT03806192

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Beliefs and Attitudes for Successful Implementation in Schools (BASIS)

Not Applicable

Completed

Conditions: Intervention Adoption
Implementation

Interventions: Behavioral: BASIS
Behavioral: Attention Control

First Posted Date: 2019-01-02

Last Posted Date: 2019-01-02

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT03791281

Locations: 🇺🇸
University of Washington School Mental Health Assessment, Research, and Training (SMART) Center, Seattle, Washington, United States

Impact of Physical Activity and Diet on Symptom Experience in People Living With HIV

Conditions: HIV/AIDS

Interventions: Other: No intervention

First Posted Date: 2018-12-31

Last Posted Date: 2021-06-08

Lead Sponsor: University of Washington

Target Recruit Count: 850

Registration Number: NCT03790501

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸
Fenway Institute, Boston, Massachusetts, United States

and more 1 locations

Adapting Behavioral Activation to Technology Platform

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Behavioral Activation

First Posted Date: 2018-12-21

Last Posted Date: 2022-09-16

Lead Sponsor: University of Washington

Target Recruit Count: 11

Registration Number: NCT03783533

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus
Myocardial Fibrosis
Myocardial Inflammation

Interventions: Other: Placebo
Drug: dapagliflozin

First Posted Date: 2018-12-20

Last Posted Date: 2023-12-29

Lead Sponsor: University of Washington

Target Recruit Count: 62

Registration Number: NCT03782259

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

MBCT and CBT for Chronic Pain in Multiple Sclerosis

Not Applicable

Conditions: Multiple Sclerosis

Interventions: Behavioral: MBCT
Behavioral: CBT

First Posted Date: 2018-12-20

Last Posted Date: 2022-04-18

Lead Sponsor: University of Washington

Target Recruit Count: 273

Registration Number: NCT03782246

Locations: 🇺🇸
UW Medicine Multiple Sclerosis Center, Seattle, Washington, United States

Trial of Adherence App for Buprenorphine Treatment (TAAB) Study

Not Applicable

Completed

Conditions: Opioid-Related Disorders

Interventions: Behavioral: Video-based DOT Application

First Posted Date: 2018-12-19

Last Posted Date: 2021-10-06

Lead Sponsor: University of Washington

Target Recruit Count: 78

Registration Number: NCT03779997

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
Boston University, Boston, Massachusetts, United States

Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Phase 2

Terminated

Conditions: Hodgkin's Lymphoma

Interventions: Biological: Pembrolizumab
Drug: Umbralisib

First Posted Date: 2018-12-17

Last Posted Date: 2023-05-03

Lead Sponsor: University of Washington

Target Recruit Count: 6

Registration Number: NCT03776864

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Factors Affecting the Speed of Recovery After ACL Reconstruction

Not Applicable

Completed

Conditions: ACL - Anterior Cruciate Ligament Rupture
ACL Injury
Anterior Cruciate Ligament Injury

Interventions: Procedure: Adductor Nerve Block
Procedure: Femoral Nerve Block
Other: No Block

First Posted Date: 2018-12-10

Last Posted Date: 2018-12-10

Lead Sponsor: University of Washington

Target Recruit Count: 48

Registration Number: NCT03770806

Locations: 🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy